Breaking News Instant updates and real-time market news.

LMT

Lockheed Martin

$315.68

1.1 (0.35%)

15:00
10/06/17
10/06
15:00
10/06/17
15:00

Lockheed Martin awarded $9.4M missile-defense contract

The U.S. Missile Defense Agency awarded Lockheed Martin a nine-month, $9.4M contract to develop a low power laser demonstrator missile interceptor concept, the agency announced. A missile's boost phase, the short window after its launch, is the ideal time to intercept and destroy the threat, before it can reach top speed or deploy decoys. The speed and precision of laser systems make them potential options for a future missile defense system. Lockheed Martin will draw from expertise in laser system architectures, ballistic missile defense system integration, platform integration, optics and beam control for the low power laser demonstrator program. The company has experience in developing laser systems through both government contracts and internal investments, which reduces risk for its demonstrator program.

  • 24

    Oct

LMT Lockheed Martin
$315.68

1.1 (0.35%)

08/14/17
SBSH
08/14/17
NO CHANGE
SBSH
Buy
Lockheed wins $8B contract over L3 and CACI, says Citi
Citi analyst Jason Gursky says the U.S. Special Ops Command Friday after the close awarded the Special Operations Forces Global Logistics Support Services contract to incumbent Lockheed Martin (LMT) over L3 Technologies (LLL), CACI (CACI) and potentially others. The $8B contract over multiple years is a positive development for Lockheed's MFC segment and an "incremental negative" for L3, the analyst tells investors in a research note. He believes CACI's bid "was always a long shot given the level of competition." Gursky has Buy ratings on all three names.
09/06/17
STFL
09/06/17
NO CHANGE
STFL
Stifel says United Tech deal strategic, not a sign of M&A 'floodgates opening'
Stifel analyst Joseph DeNardi said one of the only risks he sees to defense stocks' multiples would be a shift in cash deployment strategy from a focus on dividends and buybacks to M&A. However, he views United Technologies' (UTX) planned acquisition of Rockwell Collins (COL) as strategic and largely focused on its desire to regain leverage against Boeing (BA) and Airbus (EADSY) and not indicative of the M&A "floodgates opening" in the defense sector. Other publicly traded companies in the defense space include BAE Systems (BAESY), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
09/18/17
STFL
09/18/17
NO CHANGE
STFL
Hold
Other bidders unlikely to challenge Northrop for Orbital ATK, says Stifel
Stifel analyst Joseph DeNardi thinks the deal to acquire Orbital ATK (OA) makes sense for Northrop Grumman (NOC) given the complimentary nature of their main business lines. He also thinks other bidders seem unlikely, since he believes Lockheed Martin (LMT) would face anti-trust issues. DeNardi has a Hold rating on Northrop shares.
09/29/17
DBAB
09/29/17
UPGRADE
Target $210
DBAB
Buy
Deutsche sees rise in missile defense spending, upgrades Raytheon
Deutsche Bank analyst Myles Walton upgraded Raytheon (RTN) to Buy from Hold and raised his price target for the shares to $210 from $180. Raytheon is the most exposed to missile defense trends, Walton told investors earlier in a research note. He believes the politics and growing missile threats to U.S. territory are "setting the table for another leg up" in missile defense spending after declining nearly 25% over the last decade. The analyst sees his other Buy-rated defense names, including Northrop Grumman (NOC) and Lockheed Martin (LMT), benefiting as well. Walton raised his price target for Northrop to $325 from $285 and for Lockheed to $340 from $305.

TODAY'S FREE FLY STORIES

MLNX

Mellanox

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Recommendations
Mellanox analyst commentary  »

Mellanox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

RDHL

RedHill Biopharma

$6.26

0.05 (0.81%)

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Earnings
RedHill Biopharma reports Q4 EPS (26c), consensus (60c) »

Reports Q4 revenue $2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

07:43
02/22/18
02/22
07:43
02/22/18
07:43
Conference/Events
JPMorgan to hold a conference »

Korea Conference will be…

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees FY18 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Conference/Events
Deutsche Bank to hold a conference »

Indonesia Corporate Days…

ROKU

Roku

$51.10

-0.08 (-0.16%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 21

    Mar

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees Q1 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

AKBA

Akebia

$14.31

0.69 (5.07%)

, CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

07:41
02/22/18
02/22
07:41
02/22/18
07:41
Conference/Events
RBC Capital to hold a conference »

Global Healthcare…

AKBA

Akebia

$14.31

0.69 (5.07%)

CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

RDUS

Radius Health

$37.71

-0.51 (-1.33%)

TYME

Tyme Technologies

$3.37

-0.06 (-1.75%)

HCA

HCA Healthcare

$100.35

-0.65 (-0.64%)

ARAY

Accuray

MDRX

Allscripts

$13.57

0.335 (2.53%)

ABEO

Abeona Therapeutics

$11.70

0.1 (0.86%)

SGEN

Seattle Genetics

$54.11

-0.05 (-0.09%)

INSY

Insys Therapeutics

$7.93

0.34 (4.48%)

SPPI

Spectrum

$20.51

0.21 (1.03%)

SPH

Suburban Propane

$24.10

-0.2 (-0.82%)

AIMT

Aimmune

$32.21

-2.75 (-7.87%)

DEPO

Depomed

$7.46

0.07 (0.95%)

KTWO

K2M Group

$19.09

-0.01 (-0.05%)

INOV

Inovalon

$11.68

-1.025 (-8.07%)

IMMU

Immunomedics

$16.38

0.16 (0.99%)

OVID

Ovid Therapeutics

$6.83

-0.2 (-2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 11

    Mar

  • 14

    Mar

  • 01

    May

  • 03

    May

  • 22

    Feb

HSC

Harsco

$16.75

0.45 (2.76%)

07:40
02/22/18
02/22
07:40
02/22/18
07:40
Earnings
Harsco reports Q4 EPS ex-items 20c, consensus 14c »

Reports Q4 revenue $455M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

WPC

W.P. Carey

$59.53

-0.73 (-1.21%)

07:40
02/22/18
02/22
07:40
02/22/18
07:40
Hot Stocks
W.P. Carey enters into 18-year triple net lease with Astellas Institute »

W. P. Carey has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

07:40
02/22/18
02/22
07:40
02/22/18
07:40
General news
Fed's Quarles anticipates further gradual tightening »

Fed's Quarles…

ROCK

Gibraltar Industries

$31.75

0.35 (1.11%)

07:39
02/22/18
02/22
07:39
02/22/18
07:39
Earnings
Gibraltar Industries sees FY18 adjusted EPS $1.96-$2.08, consensus $1.81 »

Gibraltar is providing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$109.06

-1.92 (-1.73%)

07:39
02/22/18
02/22
07:39
02/22/18
07:39
Recommendations
Chevron analyst commentary  »

Chevron weakness a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRC

Brady

$38.05

0.1 (0.26%)

07:38
02/22/18
02/22
07:38
02/22/18
07:38
Earnings
Brady reports Q2 EPS 8c, may not be compared to consensus 44c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ROCK

Gibraltar Industries

$31.75

0.35 (1.11%)

07:38
02/22/18
02/22
07:38
02/22/18
07:38
Earnings
Gibraltar Industries sees Q1 adjusted EPS 23c-28c, one est. 30c »

For Q1, the company is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCN

Welltower

$53.99

-0.81 (-1.48%)

07:37
02/22/18
02/22
07:37
02/22/18
07:37
Earnings
Welltower sees 2018 normalized FFO $3.95-$4.05, consensus $4.20 »

Expects average blended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ARWR

Arrowhead

$5.54

-0.11 (-1.95%)

07:36
02/22/18
02/22
07:36
02/22/18
07:36
Hot Stocks
Arrowhead receives regulatory clearance to begin Phase 1 study of ARO-AAT »

Arrowhead Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AABA

Altaba

$75.11

0.52 (0.70%)

07:36
02/22/18
02/22
07:36
02/22/18
07:36
Recommendations
Altaba analyst commentary  »

Altaba price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

HCN

Welltower

$53.99

-0.81 (-1.48%)

07:36
02/22/18
02/22
07:36
02/22/18
07:36
Earnings
Welltower reports Q4 normalized FFO $1.02, consensus $1.04 »

Reports Q4 revenue $1.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ROCK

Gibraltar Industries

$31.75

0.35 (1.11%)

07:35
02/22/18
02/22
07:35
02/22/18
07:35
Earnings
Gibraltar Industries reports Q4 adjusted EPS 41c, consensus 34c »

Reports Q4 revenue $258M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGEN

Repligen

$32.40

0.64 (2.02%)

07:35
02/22/18
02/22
07:35
02/22/18
07:35
Earnings
Repligen sees FY18 adjusted EPS 68c-72c, consensus 72c »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SRCL

Stericycle

$74.91

-0.31 (-0.41%)

07:35
02/22/18
02/22
07:35
02/22/18
07:35
Recommendations
Stericycle analyst commentary  »

Stericycle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAWS

Lawson Products

$23.80

0.3 (1.28%)

07:35
02/22/18
02/22
07:35
02/22/18
07:35
Earnings
Lawson reports Q4 EPS $2.21 including items, may not compare to two est. 16c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

C

Citi

$77.00

0.54 (0.71%)

, WFC

Wells Fargo

$59.73

-0.22 (-0.37%)

07:35
02/22/18
02/22
07:35
02/22/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

C

Citi

$77.00

0.54 (0.71%)

WFC

Wells Fargo

$59.73

-0.22 (-0.37%)

GM

General Motors

$40.56

-0.21 (-0.52%)

P

Pandora

$4.87

-0.46 (-8.63%)

ILG

ILG

$32.31

0.12 (0.37%)

BHGE

Baker Hughes

$26.76

0.32 (1.21%)

SLCA

U.S. Silica

$25.15

-5.6 (-18.21%)

RF

Regions Financial

$19.62

0.22 (1.13%)

SPB

Spectrum Brands

$100.87

-1.03 (-1.01%)

MNST

Monster Beverage

$65.02

0.42 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 13

    Mar

  • 15

    Mar

  • 30

    May

FCN

FTI Consulting

$43.18

-0.06 (-0.14%)

07:34
02/22/18
02/22
07:34
02/22/18
07:34
Earnings
FTI Consulting sees FY18 EPS $2.35-$2.65, consensus $2.25 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 05

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.